Last reviewed 24 May 2022
NHS England has revealed that the development of a “long-term NHS vaccination service” has now commenced.
NHS England board papers stated: “Opportunities for alignment and co-administration including catch up across all our vaccination programmes continues and the development of a long-term NHS Vaccination service has commenced.”
The papers added that NHS England is working with NHS Digital and NHS X to “design a vision and a future operating model that works across Covid-19, flu and wider routine immunisations” for the longer term and that preparations for the 2022–2023 flu season are near completion.
A campaign will also launch in the next three months to increase uptake of the measles, mumps and rubella vaccine amid a measles surge.
It was confirmed that all central directorates were working together to identify suitable data sources for use in the “Core20Plus5 methodology in screening and immunisations” to identify and address deprivation and ethnicity inequalities in uptake and coverage.
Work “continues to increase uptake of the (Covid-19) vaccination offer by pregnant women, non-age based high-risk cohorts” as well as on increasing confidence in under-served communities like African, Black Caribbean and Pakistani communities to maximise uptake.
As of 3 May 2022, over 122.7 million Covid-19 vaccinations were administered in England, consisting of over 44.7 million first doses, 41.8 million second doses, 32.7 million booster/third doses and 3.4 million booster/fourth doses, with good capacity remaining across the network through all delivery models, according to the paper.
It also said excellent progress continues to be made on the spring booster programme, with over half (2.7 million) of all those that will become eligible by the end of the programme now vaccinated.
The NHS England board papers are available to view here.